## Clinical Diagnosis: Hepatopulmonary Syndrome (HPS) ### Key Clinical Features **Key Point:** Hepatopulmonary syndrome is a pulmonary vascular dilatation disorder in cirrhotic patients, characterized by intrapulmonary shunting leading to hypoxaemia with preserved cardiac function. ### Diagnostic Criteria for HPS | Criterion | Finding in This Case | Significance | |-----------|----------------------|---------------| | **Liver disease** | Cirrhosis (Child C) | ✓ Present | | **Intrapulmonary shunting** | PaO₂ 58 mmHg (room air) | ✓ Hypoxaemia | | **Alveolar-arterial gradient** | A-a = 150 - (28 + 21) - 58 = 43 mmHg | ✓ >15 mmHg (abnormal) | | **Cardiac function** | Normal EF, normal echo | ✓ Preserved | | **Chest imaging** | Clear (no infiltrates, no cardiomegaly) | ✓ Normal | | **Contrast bubble study** | Not done, but clinical picture fits | Opacification in left heart >3 beats = RL shunt | **High-Yield:** The combination of **cirrhosis + hypoxaemia (PaO₂ 58) + normal cardiac function + clear chest X-ray + elevated A-a gradient** is pathognomonic for HPS. The absence of pulmonary infiltrates, cardiomegaly, and thrombus rules out other diagnoses. ### Pathophysiology 1. **Intrapulmonary vascular dilatations** (microscopic precapillary and capillary) 2. **Right-to-left shunting** of blood through dilated vessels 3. **Impaired oxygen diffusion** and ventilation-perfusion mismatch 4. **Vasoactive mediators** (nitric oxide, endothelin dysregulation) 5. **Result:** Hypoxaemia despite normal lungs and normal cardiac output **Clinical Pearl:** HPS is often called the "pulmonary manifestation of portal hypertension." It occurs in 5–32% of cirrhotic patients and is a leading indication for liver transplantation. ### Distinguishing Features from Other Diagnoses #### Why NOT Hepatic Hydrothorax? - Hydrothorax presents with **pleural effusion on imaging** (this patient has clear chest X-ray) - Dyspnoea is due to mechanical compression, not hypoxaemia - PaO₂ would be normal or only mildly low - No A-a gradient elevation #### Why NOT Spontaneous Bacterial Empyema? - Would require **fever, elevated WBC, positive pleural fluid culture** - Pleural effusion would be visible on imaging - No mention of fever or systemic infection #### Why NOT Portopulmonary Hypertension (POPH)? - POPH causes **pulmonary arterial hypertension** (mPAP >25 mmHg) - Echocardiography would show **elevated RV systolic pressure** and RV dilatation - This patient's echo is normal - POPH presents with dyspnoea on exertion; HPS can present at rest - POPH is less common than HPS in cirrhotic populations **Mnemonic: HPS vs POPH** — **HPS = Hypoxaemia (shunt), normal echo** | **POPH = Pulmonary hypertension, elevated RV pressure on echo** ### Diagnostic Workup for HPS 1. **Arterial blood gas** — hypoxaemia (PaO₂ <80 mmHg on room air at sea level) 2. **Alveolar-arterial gradient** — A-a >15 mmHg 3. **Chest X-ray** — clear (rules out other lung disease) 4. **Echocardiography** — normal cardiac function, rules out POPH 5. **Contrast-enhanced echocardiography (bubble study)** — opacification of left heart >3 cardiac cycles = RL shunt (gold standard) 6. **Technetium-99m macroaggregated albumin scan** — alternative for detecting RL shunt **Key Point:** Contrast bubble study is the gold standard for confirming intrapulmonary RL shunting in HPS. ### Management 1. **Oxygen therapy** — improve PaO₂, reduce dyspnoea 2. **Vasodilators** — inhaled nitric oxide, sildenafil (limited evidence) 3. **Liver transplantation** — **only definitive cure** (HPS resolves post-transplant) 4. **Supportive care** — avoid hepatotoxic drugs **Clinical Pearl:** HPS is a strong indication for liver transplantation, even in early stages. Untreated HPS carries poor prognosis; transplantation can reverse the pulmonary vascular dilatation. [cite:Harrison 21e Ch 304]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.